Simris Group AB OMXSTO:SIMRIS_B:
ANNOUNCES POSITIVE RESULTS FROM ONGOING ANTIBODY-DRUG CONJUGATE (ADC) STUDY WITH NUVISAN
SIMRIS-121 TO PROCEED TO NEXT STAGE OF NUVISAN STUDY
DOSE-ESCALATION IN-VIVO STUDY TO DETERMINE MTD OF ADC IN MICE
Simris Group AB OMXSTO:SIMRIS_B:
ANNOUNCES POSITIVE RESULTS FROM ONGOING ANTIBODY-DRUG CONJUGATE (ADC) STUDY WITH NUVISAN
SIMRIS-121 TO PROCEED TO NEXT STAGE OF NUVISAN STUDY
DOSE-ESCALATION IN-VIVO STUDY TO DETERMINE MTD OF ADC IN MICE